CTOs on the Move

Avinger

www.avinger.com

 
Avinger, Inc. is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems for the treatment of patients with peripheral artery disease (PAD). PAD is characterized by a build-up of plaque in the arteries that supply blood to the arms and legs. The company’s mission is to radically change the way vascular disease is treated through the introduction of products based on its lumivascular platform, the only intravascular image-guided system of therapeutic catheters available in this market. Avinger’s current lumivascular products include the Lightbox imaging console, the Ocelot family of catheters, which are designed to penetrate total ...
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.avinger.com
  • 400 Chesapeake Dr
    Redwood City, CA USA 94063
  • Phone: 650.363.2400

Executives

Name Title Contact Details

Funding

Avinger raised $18M on 02/14/2018
Avinger raised $11.5M on 11/07/2018

Similar Companies

Smart MD

Smart MD is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Siemens Healthcare Diagnostics

Siemens Healthcare Diagnostics is a Deerfield, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Conor Medsystems

Conor Medsystems, Inc. develops controlled vascular drug delivery technologies. It has initially focused on the development of drug-eluting stents to treat coronary artery disease. Its stents have been specifically designed for vascular drug delivery, in

TriVascular

TriVascular has pioneered numerous design and manufacturing technologies in pursuit of our commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular`s initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, TriVascular`s products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR.

Analogic

Founded in 1988 in Queensbury, N.Y., U.S., AngioDynamics is today a NASDAQ-listed public company. We are a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease. Our diverse product line includes market-leading radiofrequency ablation and NanoKnife® systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. AngioDynamics has distinguished itself as a dynamic brand in a technologically competitive, high-growth industry, through the company’s consistent ability to successfully develop and bring to market new technologies and products. AngioDynamics believes it is well poised to continue that trend. Looking into the future, the company plans to bring forth a continuing stream of innovations that greatly improve patient care by providing the highest-quality, best-performing products.